CoChat

Role of p38 MAP kinase in LPS‐induced airway inflammation in the rat

Open access
Haddad, El‐Bdaoui, Birrell, Mark, McCluskie, Kerryn, Ling, Andrea, Webber, Stephen E, Foster, Martyn L, Belvisi, Maria G · 2001 · British Journal of Pharmacology
Cited by 88

The DOI matches its Crossref record.

Abstract

We investigated the effect of the p38 kinase inhibitor SB 203580 on airway inflammation induced by aerosolized lipopolysaccharide (LPS) in male Wistar rats. SB 203580 significantly inhibited (ED 50=15.8 mg kg−1) plasma levels of TNF‐α in rats challenged with LPS (1.5 mg kg−1, i.p.). Aerosolized LPS induced a peak in TNF‐α levels and the initiation of a neutrophilic response in bronchoalveolar lavage (BAL) fluid at the 2 h time point. Furthermore, the 4 h time point was associated with the peak in IL‐1β levels and the initial plateau of neutrophilia observed in the BAL fluid. SB 203580 (100 mg kg−1), had no effect on peak TNF‐α levels or the associated neutrophilia in the BAL. Interestingly, the PDE 4 inhibitor RP 73401 (100 mg kg−1) significantly reduced both TNF‐α levels and neutrophilic inflammation. However, the BAL fluid from rats pre‐treated with either compound significantly inhibited TNF‐α release from cultured human monocytes 18 h after LPS treatment (83.6 and 44.5% inhibition, respectively). Alternatively, SB 203580 (100 mg kg−1) produced dose‐related inhibition of BAL IL‐1β levels (67.5% inhibition, P<0.01) and BAL neutrophilia (45.9% inhibition, P<0.01) 4 h after LPS challenge. P38 protein was present in lung tissue and the level of expression was not affected by LPS treatment. P38 kinase appears to be involved in the release of IL‐1β and the sustained neutrophilic response in the BAL fluid. This data may suggest a role for p38 inhibitors in the treatment of airway inflammatory diseases in which neutrophilia is a feature of the lung pathology. British Journal of Pharmacology (2001) 132, 1715–1724; doi:10.1038/sj.bjp.0704022

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0704022

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Haddad, E., Birrell, M., McCluskie, K., Ling, A., Webber, S. E., Foster, M. L., & Belvisi, M. G.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2001-04
Volume
132
Issue
8
Pages
1715-1724
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2143778995
Cited by
88
References
0
FWCI
2.39
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.